THE 2-NITROIMIDAZOLE, misonidazole (MISO), is currently undergoing clinical trials because of its radiosensitizing and cytotoxic effects on hypoxic tumour cells (Dische et al., 1977) . It has been proposed that its effectiveness towards hypoxic cells is due to the anaerobic reduction of the drug which produces a metabolite capable of binding to the cell's DNA. This may cause lesions, DNA degradation and eventual cell death (Palcic & Skarsgard, 1978) . Other experimental approaches, however, have suggested that the mechanism of MISO toxicity may be similar under both aerobic and hypoxic conditions, and that the primary effect is not necessarily at the level of the cellular DNA (Stratford & Gray, 1978) but may involve other cellular processes, such as mitochondrial activity (Mustea et al., 1978) . AsMISO enters normal tissues in humans at about the same levels as in solid tumours (Ash et al., 1979) , investigations on aerobic cells as well as hypoxic systems are required. In considering the effects of chemicals at microscopic or submicroscopic levels, there are often advantages in using model systems rather than whole animals (Walton & Buckley, 1975) . One such system that has gained acceptance in toxicological studies is the protozoan, Amoeba proteus (for review see Ord, 1979) . This system was considered potentially useful in studying the action of MISO, since the effects of anaerobiosis on the cell have already been monitored and, as the amoeba has a high resistance to X-rays (Ord & Danielli, 1956 ) any sensitizing effects should easily be determined. The present report details the preliminary ultrastructural findings with MISO treatments of aerobic amoebae. The effects of hypoxic culturing will form the basis of a subsequent communication. Morphological changes to the mitochondria were noted, which included the generation of matrical inclusions. Similar changes of form have been correlated with a disruption of mitochondrial functioning (Smith & Ord, 1979; Smith et al., 1979) , and the possible significance of the present results is discussed in the light of these.
Amoeba proteus, Strain PDaX69, was maintained at 20°C, as described by Smith & Ord (1979) . Dividing cells were selected from mass culture, grouped into synchronized samples, and treated at an age of 1 h (early S-phase) with freshly prepared MISO at concentrations of 10-20 mm (corresponding to the MISO doses used by Mustea et al. (1978) in treatments of Ehrlich ascites cells). In human patients for radiotherapy much lower plasma levels (0.16-0-78 mM) were recorded after oral administration (Dische et al., 1977 exposures (from 1 to 5 days) and at intervals following the removal of MISO from the amoeba medium. These amoebae were compared with untreated, healthy controls. EM preparatory stages were as previously reported except that 0.5% tannic acid was added to the 4% formaldehyde/5% glutaraldehyde fixative to improve preservation.
MISO treatments induced no detectable changes in nuclear morphology at the concentrations used. In the cytoplasm the major structural alteration was seen in the mitochondria, although the Golgi-body norphology was also affected. The mitochondria of A. proteus after aldehyde fixation appear as 2 distinct types coexisting within individual, untreated cells (Fig. 1) . These types persisted after 5h MISO treatments, but by 18 h the constricted form had disappeared. In cells incubated in MISO for 18 h the mitochondria were characterized by the presence of groups of parallel, filamentous inclusions within the matrix (Fig. 2) . When the MISO exposures were extended, granular bodies were also evident in the intermediatedense matrix, while the cristae had become dilated (Fig. 3) . The frequency of inclusions increased from -32% profiles scored at 18 h, to 70-80% by 2-4 days, suggesting that by this time all mitochondria were affected. Large numbers of the granular inclusions were seen on Days 4 and 5 of treatment, whereas the filamentous bodies were less commonly en- countered. This suggested that the granular bodies developed from the filamentous inclusions. Twenty-four hours after removal of MISO from the medium, the mitochondrial inclusions remained, although as the recovery period was extended the frequency of both types of inclusion decreased. Dense granular inclusions have previously been reported in amoeba mitochondria after ethidium bromide (EB) administration, and were thought to develop from the disruption and intercalation of mitochondrial DNA (Flickinger, 1973) . S-phase amoebae were therefore treated with EB in the present study to ascertain any structural similarity between these and the inclusions generated by MISO. EB doses of 0-1-0 25 mm for 4 h caused the appearance of dense granules in the mitochondrial matrix. The cristal membranes were also affected, showing signs of disorganization. As with MISO treatments, EB-induced inclusions persisted for 24 h in the mitochondria of cells returned to amoeba medium without the drug (Fig. 4) . Certain similarities were evident between the effects of MISO and EB, and it is suggested that their action on the mitochondria may be related in aerobic amoebae. The possibility that the MISO-induced inclusions are at least partly composed of nucleic acids is currently under investigation.
The present results indicate that MISO (Smith & Ord, 1979) . The investigation may now be extended to determine whether hypoxic culturing increases MISO toxicity in this system, as might be expected from our other studies . MISO incubations will also be carried out at higher temperatures as the low growth temperature routinely used may explain why relatively long exposures are required in the present work. Mitochondrial form in amoeba can certainly be influenced by growth temperature (Smith, 1979) and in mammalian cells MISO cytotoxicity is enhanced by hyperthermia (Stratford & Adams, 1977) . Mustea et al. (1978) considered thatMISO acted on mitochondria by uncoupling oxidative phosphorylation. They suggested that its toxicity could then result from a decrease in ATP levels within the cell, causing a reduction in the potential for repair pathways. The present study adds support to the proposal that one site of action by MISO in a cell is the mitochondria, and indicates that in further investigations to elucidate the mechanisms of MISO toxicity, the effect on mitochondrial activity should be considered.
